Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
DeNovaMed
company
About
DeNovaMed is an early-stage pharmaceutical company.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $500K
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2006
- Number Of Employee
- 11 - 50
- Operating Status
- Active
DeNovaMed is an early-stage pharmaceutical company specializing in new therapeutic approaches to combat bacterial infections. Their team has deep domain expertise in drug discovery, microbiology, and bacterial lipid metabolism, which they use to create novel antibiotics. DeNovaMed is based in Halifax, Nova Scotia, Canada.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$500K
DeNovaMed has raised a total of
$500K
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2012 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2012 | Seed | $500K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
DeNovaMed is funded by 1 investors.
Innovacorp
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Innovacorp
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
